How it works
Get started by filling out the online enrollment application to find out if you are eligible for assistance.
NiceRx verifies your eligibility for medication assistance and notifies you if you are pre-qualified. The pharmaceutical company provides your medication for free, and you only pay our service fee.
We will request documents to be submitted by you and your healthcare provider that are required by the pharmaceutical company to complete your enrollment.
Once approved, the pharmaceutical company typically ships a 90-day supply of medication to your home or healthcare provider’s address. Final acceptance is determined by the pharmaceutical company.
Your monthly Elitek cost savings if eligible
If you are eligible for the Elitek patient assistance program you can receive your medication for free. Our monthly service fee of $49 per medication covers the cost of our services in applying for the program and requesting your ongoing refills on your behalf. If you obtain your Elitek through NiceRx, you will only pay $49 a month regardless of the retail price of your medication.
Am I eligible for the Elitek patient assistance program?
You could receive your Elitek without paying the full retail price if you meet the eligibility criteria for assistance. The eligibility requirements are set by the pharmaceutical companies that are providing assistance programs. At NiceRx, we review each application individually, although the main factors considered by most programs are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for Elitek patient assistance?
We do everything that we can to take the hassle and stress out of applying for patient assistance programs. Simply start by filling in our enrollment application. We will ask for details about your healthcare provider, your insurance, and your household income. This information is required by the pharmaceutical companies you are applying to for assistance. We may also be able to help you access patient assistance for other medications that you have been prescribed, so be sure to tell us about any medications you are taking as well as Elitek.
NiceRx will review the information you have provided, and if we determine that you may be eligible for assistance, we will seek to enroll you in the Elitek patient assistance program. We will handle the enrollment process for you by working with your healthcare provider and preparing all the required paperwork for your doctor to sign. We will also request your Elitek medication refills on your behalf for up to 1 year once you are enrolled in the program.
Is NiceRx an Elitek coupons provider?
At NiceRx, we help eligible individuals access the Elitek patient assistance program. This means that we are not an Elitek coupon, an Elitek discount card, or an Elitek copay card provider. We do not offer any medication trial offers or free Elitek samples.
Can NiceRx help me get Elitek if I have insurance?
We may be able to help you if you have insurance, including if your insurance company will not pay for your Elitek medication, or you have a high copay or coinsurance responsibility. We may even be able to assist if you do not have insurance. Please fill in our enrollment application to find out more.
How much does Elitek cost without insurance?
Elitek costs without insurance will vary depending on how much you buy and the retailer you buy it from. As a guide, Elitek intravenous powder for injection 1.5 mg will typically cost around $3,000 for 3 powders for injection. If you obtain your medication through NiceRx, you will pay a flat monthly rate of $49 per medication regardless of its retail price.
How much does Elitek cost with insurance?
The copay of Elitek will vary in line with the specific terms of your healthcare plan. For further details about what you may need to pay, your insurance provider or pharmacist will be able to calculate the copay costs with your current insurance.
What is Elitek?
Elitek is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Sanofi-Aventis. Elitek is a recombinant urate-oxidase indicated for initial management of increased plasma uric acid levels (Hyperuricemia) in pediatric and adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) and subsequent elevation of plasma uric acid.
Elitek can cause severe hypersensitivity reactions including anaphylaxis. Discontinue immediately if a serious hypersensitivity reaction occurs. Symptoms include bronchospasm, chest pain and tightness, dyspnea, hypoxia, hypotension, shock, and urticaria). Do not administer Elitek to patients with glucose-6- phosphate dehydrogenase (G6PD) deficiency. Immediately discontinue Elitek if hemolysis occurs. Screen patients at higher risk for G6PD deficiency (patients of African or Mediterranean ancestry) prior to therapy. Immediately and permanently discontinue Elitek if methemoglobinemia occurs.
Interference with uric acid measurements – Elitek enzymatically degrades uric acid in blood samples left at room temperature. Collect blood samples in pre-chilled tubes containing heparin and immediately immerse and maintain the sample in an ice water bath. Assay plasma samples within 4 hours of collection.
What doses of Elitek are available?
Elitek is available in powder form, in the following doses: 1.5 mg powder per single-use vial, 7.5 mg powder per single-use vial
The recommended daily dose of rasburicase is 0.2 mg/kg as an intravenous infusion over 30 minutes for up to 5 days. Do not administer as an intravenous bolus.
Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Elitek active ingredients
Elitek contains the active ingredient rasburicase, a recombinant urate oxidase enzyme. Rasburicase’s mechanism of action is to catalyze enzymatic oxidation of poorly soluble uric acid into an inactive and more soluble metabolite, allantoin.
Elitek side effects
The most common side effects of Elitek in clinical trials include:
- Vomiting, nausea
- Peripheral edema
- Abdominal pain
- Constipation, diarrhea
In rare instances, Elitek can cause more serious adverse reactions. These can include:
- Anaphylaxis, Hemolysis, Methemoglobinemia, See laboratory sample handling procedure – See Boxed warning
Your doctor will assess the benefits of using Elitek against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Elitek to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Elitek drug interactions
There is currently no data for Elitek interactions with other medications. However, other drugs may affect rasburicase, including prescription drugs and over-the-counter medicines, vitamins, and herbal products.
You should not use Elitek if you:
- Are allergic to the active ingredient rasburicase
- Have had an allergic reaction to any of the other ingredients in Elitek
- Are pregnant or are planning to become pregnant
- Have a history of the following reactions to rasburicase – anaphylaxis, severe hypersensitivity, hemolysis, methemoglobinemia, or Glucose-6-phosphate dehydrogenase (G6PD) deficiency (a hereditary metabolic disorder affecting red blood cells)
Talk to your doctor before using Elitek to get medical advice if you:
- Are taking any of the medications that could interact with Elitek
- Breastfeeding is not recommended during treatment and for 2 weeks after the last dose
Elitek is the trademark brand name for rasburicase manufactured by Sanofi-Aventis. A generic version of rasburicase is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Elitek savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.